Generic Drugs as Market Disruptors: Why CVS, Perrigo Will Benefit

By Chat Reynders  APR 28, 2014 1:53 PM

The market players who are positioned to lead a new surge in generic drug sales are making huge strides.

 


Reynders, McVeigh Capital Management, LLC ("RMCM") does not directly or indirectly beneficially own any of the securities identified in this video and article.

All of the specific health care-related securities identified in this video and article are current recommendations of Reynders, McVeigh Capital Management, LLC ("RMCM") on behalf of its advisory clients.  The specific securities identified and described do not represent all of the securities purchased, sold, or recommended for RMCM's advisory clients.  The audiencee should not assume that investments in the securities identified and discussed were or will be profitable. RMCM also currently recommends numerous other securities in various other industries unrelated to health care.  The purchase of these health care-related securities only will not create a diversified portfolio.  In addition, the securities identified in this article may be past specific recommendations of RMCM.  If such securities are past specific recommendations, RMCM shall upon request furnish a list of all recommendations made by RMCM during the twelve months prior to the date of this advertisement.  It should not be assumed that recommendations made in the future will be profitable or will equal the performance of the securities provided in this list.  Past performance is not indicative of future results.